Specialty Pharmacy

Novel agents using dill and parsley extracts show promise fighting cancer.

Ocrevus is an investigational, humanized monoclonal antibody that selectively targets CD20-positive B cells in multiple sclerosis.

Epclusa showed up to 99% viral suppression after 12 weeks across major hepatitis C genotypes.

Presence of different antibodies in the blood can influence response to abatacept regimen.

More work is need to determine the impact of weight loss programs in lowering blood sugar concentrations in type 2 diabetes.

Targeting cancer-driving proteins may further efforts in personalized cancer medication research.

Design of formulations based on flavopiridol shows promise inhibiting brain cancer cell growth.

Top news of the day from across the health care landscape.

Some injection drug users with HIV and hepatitis C seem to have the same immune problems as the elderly.

The research and development process for prescription drugs could be streamlined with large-scale prospective biobank studies.

Caregivers need to carefully monitor comorbidities that accompany a COPD diagnosis.

Fenofibrate with 2-Deoxy-D-glucose shows success treating a variety of cancers.

Top news of the day from across the health care landscape.

Higher doses of radiation found as effective as lower dose radiation for breast cancer treatment.

Digestive hormone found to reduce liver fibrosis associated with cholestasis.

Protease inhibitors can frequently lead to cardiovascular disease, diabetes, and obesity.

Rinku A. Patel, PharmD, RPh, founder and CEO of KloudScript, discusses the optimal use of technology and data to improve patient care in specialty pharmacies.

Pharmacists among 301 individuals charged for allegedly engaging in $900 million in false billings.

Top articles of the week from The American Journal of Pharmacy Benefits.

Study finds a large proportion of breast cancer patients are receiving enough follow-up heart scans.

Findings will allow for improved screenings of drugs that treat MS.

Recent advances and updates in oncology and cancer drug development.

Engineering bacteria to deliver HIV-1 neutralizing antibodies at the site where the virus enters the body may offer a cost-effective barrier to HIV-1 transmission.

“You can put yourself out of business by getting into the specialty pharmacy business.”

Ryan White HIV/AIDS Program offers medical care and services for low income, uninsured, and underinsured individuals.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of the CSI Specialty Group, discusses improved communication among specialty drug manufacturers and health care providers.

Diet and physical activity found to decrease the risk of developing multiple cancer types.

Certain characteristics could potentially make patients more likely to need assistance with their medications.